3RETSCH-BOGART G Z,QUITTNER A L,GIBSON R L,et al.Efficacy and safety of inhaled aztreonam lysine for arway pseudomonas in cystic fibrosis[J].Chest,2009,135(5):1223.
8FRANK L D, ROBERTO C, BIFFIGNANDI P,et al. Doxofylline:A new generation xanthine bronchodilator devoid of major cardiovascular adverse effects[ J ]. Curr Med Res Opin, 2001,16 (4) :258-268.
9GROSSMAN R F. The role of quinolones in upper respiratory tract in infections[J]. Curr Infect Dis Rep, 2001, 3 (3) :224- 232.
10BOLOGNA E, LAGANA A, TERRACINO D, et al. Oral and intravenous pharmacokinetic profiles of doxophylline in patients with chronic bronchitis[J]. J Int Med Res, 1990, 18 (4) :282- 288.
2Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community- acquired Pneumonia in Adults[J]. Clin In fect dis, 2007, 44 (Suppl2) : $27-$72.
